Jeff Geschwind, MD’s Cancer Drug Innovations Founder of Cage Pharma, Jeff Geschwind, MD targets cancer metabolism to create breakthrough drugs. His research on glycolysis inhibition offers new hope for aggressive cancers. https://www.linkedin.com/in/jeff-geschwind-037200174